查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球无菌测试市场：按产品,测试,应用,最终用户和地区划分的未来预测（至 2028 年）
市场调查报告书
商品编码
1241252

全球无菌测试市场：按产品,测试,应用,最终用户和地区划分的未来预测（至 2028 年）

Sterility Testing Market by Product, Test, Application, End User & Region - Global Forecasts to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 192 Pages | 订单完成后即时交付

价格
简介目录

全球无菌检测市场预计将从2023年的11亿美元增长到2028年的19亿美元，CARG为10.5%。

製药和生物技术产能增加,新型生物製药研发增加以及生命科学研究投资增加等因素预计将推动市场增长。 另一方面，一次性技术的普及和产品审批的严格监管准则预计将在一定程度上抑制市场增长。

“按产品/服务分类，试剂盒和试剂在预测期内增长最快”

通过按产品/服务查看无菌检测市场，预计试剂盒和试剂部分将成为预测期内（2023 年至 2028 年）增长最快的部分。 由于易于使用，这些试剂盒广泛用于製药和生物技术行业。 此外，较长的保留期导致教育机构和 CRO 的采用率增加。 无菌检测在药物和生物製药的临床和商业生产中必不可少。 製药和生物技术公司正在采用试剂盒和试剂进行无菌检测，因为它们具有成本效益和时间效率。

“按应用划分，2022 年製药和生物製品领域的市场份额最大”

通过按应用查看无菌检测市场，製药和生物製品製造领域将在 2022 年占据最大份额。 这一领域的增长是由全球製药和生物製品产能扩张推动的。

“按地区划分，北美在 2022 年占据了最大的地区份额”

到 2022 年，北美将按地区主导灭菌检测市场。 该地区是主要製药和生物製药公司製造设施的所在地，预计将有助于满足北美对无菌检测的巨大需求。 此外，随着药品批准率的提高，无菌检测市场有望扩大。 由于疾病的传播和患者数量的增加，北美对药品和生物製药的需求正在增加。 此外，北美的製药和生物技术行业在研发方面投入巨大，预计在未来几年内将快速增长。

在这份报告中，我们分析了全球无菌检测市场，包括市场的基本结构,最新发展,驱动和抑制市场的主要因素，以及产品/服务的类型,测试类型,应用,终端-用户，我们正在按地区调查市场趋势的前景,市场竞争状况以及主要公司的概况。

内容

第一章介绍

第二章研究方法论

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 介绍
  • 市场动态
    • 司机
    • 约束因素
    • 机会
    • 任务
  • 关税和法规
  • 波特的五力分析
  • 供应链分析
  • 技术分析
  • 参考价格
  • 专利分析
  • 生态系统分析
  • 主要会议和活动 (2023-2024)
  • 主要利益相关者和采购标准
  • 贸易分析

第 6 章无菌检测市场：按产品/服务分类

  • 介绍
  • 试剂盒和试剂
  • 服务
  • 设备

第 7 章无菌检测市场：按检测类型分类

  • 介绍
  • 膜过滤
  • 直接接种
  • 其他类型的测试

第 8 章无菌检测市场：按应用

  • 介绍
  • 药物和生物製品的製造
  • 医疗设备製造
  • 其他用途

第 9 章无菌检测市场：按最终用户分类

  • 介绍
  • 製药公司
  • 生物技术公司
  • 其他最终用户

第 10 章无菌检测市场：按地区

  • 介绍
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲国家
  • 亚洲
    • 中国
    • 日本
    • 印度
    • 韩国
    • 其他亚洲国家
  • 其他国家（行）
    • 拉丁美洲/加勒比地区
    • 太平洋和大洋洲
    • 非洲

第11章竞争格局

  • 概览
  • 主要公司采用的策略
  • 市场份额分析
  • 主要公司的收入份额分析
  • 公司评估象限
  • 商业评估象限：初创公司/中小企业
  • 竞争基准
    • 公司产品足迹
    • 公司的地理足迹
  • 竞争场景

第12章公司简介

  • 主要公司
    • MERCK KGAA
    • CHARLES RIVER LABORATORIES
    • BIOMERIEUX SA
    • SGS S.A.
    • SARTORIUS AG
    • THERMO FISHER SCIENTIFIC INC.
    • WUXI APPTEC
    • SAMSUNG BIOLOGICS
    • GENSCRIPT
    • PACIFIC BIOLABS
    • NELSON LABORATORIES, LLC
  • 其他企业
    • PACE ANALYTICAL
    • RAPID MICRO BIOSYSTEMS, INC.
    • TENTAMUS
    • SINGOTA SOLUTIONS
    • NEOPHARM LABS INC.
    • LEXAMED
    • ASTELL SCIENTIFIC LTD
    • HIMEDIA LABORATORIES
    • PALL CORPORATION (PART OF DANAHER CORPORATION)
    • BOSTON ANALYTICAL
    • SOLVIAS AG
    • BD

第13章 附录

简介目录
Product Code: BT 5095

The global sterility testing market is expected to reach USD 1.9 billion in 2028 from USD 1.1 billion in 2023 at a CARG of 10.5%. Factors such as expanding pharmaceutical & biotechnology production capacities, increasing development of novel biopharmaceutical products, and rising investments in life sciences research are expected to drive market growth. However, the growing adoption of single-use technology and stringent regulatory guidelines for product approval are expected to restrain market growth to a certain extent.

"During the forecast period, the kits & reagent is expected to account as the fastest-growing segment ."

Based on product & service, the sterility testing market is divided into kits & reagents, instruments, and services. During the forecast period (2023-2028), the kits & reagents segment is also expected to be the fastest-growing segment in the sterility testing market. Kits are widely used in the pharmaceutical and biotechnology industries as it is easy to use. Moreover, the long shelf life of these products is contributing to their rising adoption in academic institutions and contract research organizations. Sterility testing is mandatory during the clinical and commercial manufacturing of pharmaceutical & biopharmaceutical products. Pharmaceutical & biotechnology companies adopt kits & reagents for sterility testing as it is cost-effective and time-efficient.

"In 2022, by application segment, pharmaceutical & biologics accounted for the biggest market share"

Based on application, the sterility testing market is divided into pharmaceutical & biologics manufacturing, medical device manufacturing, and other applications. In 2022, the pharmaceutical and biologics manufacturing segment accounted for the largest share of the application segment in the sterility testing market. Factors responsible for the growth in this segment include the growing, growing pharmaceutical and biopharmaceutical production capacity across the globe.

"In 2022, North America accounted for the largest regional share in this market"

The market for sterility testing was dominated by North America in 2022. Presence of manufacturing facilities of major pharmaceutical and biopharmaceutical firms in the region will contribute for the huge demand for sterility testing in North America. The market for sterility testing is anticipated to grow in the region as drug approval rates rise. Also, the demand for pharmaceuticals and biopharmaceuticals in North America are rising due to the rising prevalence of diseases and the expanding patient population. Moreover, the pharmaceutical and biotechnology sectors in North America make substantial R&D investments and are anticipated to experience rapid growth in the coming years.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Respondent- Supply Side- 70%, Demand Side-30%
  • By Designation- CXOs and Directors- 30%, Executives - 25%, Mangers - 45%
  • By Region- North America - 40%, Europe - 25%, APAC - 20%, RoW- 15%

The sterility testing market is dominated by a few globally established players such as Charles River Laboratories (US), Merck KGaA (Germany), bioMerieux SA (France), SGS SA (Switzerland), WuXi AppTec (China), Nelson Laboratories, LLC (US), Pacific BioLabs (US), Sartorius AG (Germany), Thermofisher Scientific Inc. (US), and Samsung Biologics (South Korea). The study includes an in-depth competitive analysis of these key players in the sterility testing market with their company profiles, recent developments, and key market strategies.

Research Coverage:

The report segments the sterility testing market based on region (North America, Europe, Asia, and Rest of the World), by product & service (kits & reagents, instruments, and services), by test type (membrane filtration, direct inoculation, and other tests), by application (pharmaceuticals and biologicals, medical devices, and other applications), and by end user (pharmaceutical companies, biotechnology companies, and others ). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the sterility testing market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the sterility testing market and provides them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Primary sources
      • 2.1.2.3 Breakdown of primaries
    • FIGURE 2 STERILITY TESTING MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 STERILITY TESTING MARKET SIZE ESTIMATION (2022)
    • FIGURE 4 STERILITY TESTING MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
    • FIGURE 5 KEY INDUSTRY INSIGHTS
    • FIGURE 6 STERILITY TESTING MARKET: CAGR PROJECTION (2023-2028)
    • FIGURE 7 STERILITY TESTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH LIMITATIONS
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 RECESSION IMPACT
    • TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

    • FIGURE 9 STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 STERILITY TESTING MARKET, BY TEST TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 STERILITY TESTING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 STERILITY TESTING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 STERILITY TESTING MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 STERILITY TESTING MARKET OVERVIEW
    • FIGURE 14 RISING EXPANSION OF PHARMACEUTICAL & BIOPHARMACEUTICAL PRODUCTION CAPACITIES TO FUEL UPTAKE OF STERILITY TESTING SERVICES
  • 4.2 ASIA: STERILITY TESTING MARKET, BY PRODUCT & COUNTRY (2022)
    • FIGURE 15 KITS & REAGENTS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN CHINA
  • 4.3 STERILITY TESTING MARKET, BY REGION (2022)
    • FIGURE 16 ASIA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 STERILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising expansion of pharmaceutical & biopharmaceutical production capacities
      • 5.2.1.2 Increasing development of novel biopharmaceutical products
    • TABLE 2 NOVEL DRUG APPROVALS (2022)
      • 5.2.1.3 Rising investments in life sciences research
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Growing adoption of single-use technology
      • 5.2.2.2 Stringent regulatory guidelines for product approval
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
      • 5.2.3.2 Increasing outsourcing of services to sterility testing providers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals
  • 5.3 TARIF AND REGULATION
    • 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 STERILITY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 THREAT FROM NEW ENTRANTS
    • 5.4.2 THREAT FROM SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF BUYERS
    • 5.4.4 BARGAINING POWER OF SUPPLIERS
    • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 18 STERILITY TESTING MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 TECHNOLOGICAL ANALYSIS
  • 5.7 INDICATIVE PRICING
    • TABLE 8 SELLING PRICE OF STERILITY TESTING PRODUCTS
  • 5.8 PATENT ANALYSIS
    • FIGURE 19 STERILITY TESTING MARKET: PATENT TESTING APPLICATIONS (JANUARY 2012-DECEMBER 2022)
  • 5.9 ECOSYSTEM ANALYSIS
    • TABLE 9 STERILITY TESTING MARKET: SUPPLY CHAIN ECOSYSTEM
  • 5.10 KEY CONFERENCES AND EVENTS, 2023-2024
    • TABLE 10 STERILITY TESTING MARKET: CONFERENCES AND EVENTS (2023-2024)
  • 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR STERILITY TESTING PRODUCTS
    • 5.11.2 STERILITY TESTING MARKET: BUYING CRITERIA
    • FIGURE 21 KEY BUYING CRITERIA FOR END USERS
  • 5.12 TRADE ANALYSIS
    • TABLE 11 TOP 10 IMPORTERS OF MACHINERY AND APPARATUS FOR FILTERING/PURIFYING LIQUIDS (HS CODE - 842129)
    • TABLE 12 TOP 10 EXPORTERS OF MACHINERY AND APPARATUS FOR FILTERING/PURIFYING LIQUIDS (HS CODE - 842129)

6 STERILITY TESTING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 13 STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • 6.2 KITS & REAGENTS
    • 6.2.1 RISING DEMAND FOR STANDARD STERILITY TESTING TO DRIVE MARKET
    • TABLE 14 STERILITY TESTING MARKET FOR KITS & REAGENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 15 NORTH AMERICA: STERILITY TESTING MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 16 EUROPE: STERILITY TESTING MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 ASIA: STERILITY TESTING MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 REST OF THE WORLD: STERILITY TESTING MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 SERVICES
    • 6.3.1 GROWING TREND OF OUTSOURCING SERVICES TO CROS TO DRIVE MARKET
    • TABLE 19 STERILITY TESTING MARKET FOR SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 20 NORTH AMERICA: STERILITY TESTING MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 EUROPE: STERILITY TESTING MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 22 ASIA: STERILITY TESTING MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 23 REST OF THE WORLD: STERILITY TESTING MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 INSTRUMENTS
    • 6.4.1 INCREASING ADOPTION OF RAPID MICROBIAL METHODS TO SUPPORT MARKET GROWTH
    • TABLE 24 STERILITY TESTING MARKET FOR INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 25 NORTH AMERICA: STERILITY TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 26 EUROPE: STERILITY TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 27 ASIA: STERILITY TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 REST OF THE WORLD: STERILITY TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)

7 STERILITY TESTING MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 29 STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
  • 7.2 MEMBRANE FILTRATION
    • 7.2.1 RISING DEMAND FOR TESTING OF DRUGS IN LIQUID DOSAGE FORMS TO FUEL ADOPTION
    • TABLE 30 STERILITY TESTING MARKET FOR MEMBRANE FILTRATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 31 NORTH AMERICA: STERILITY TESTING MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 32 EUROPE: STERILITY TESTING MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 33 ASIA: STERILITY TESTING MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 REST OF THE WORLD: STERILITY TESTING MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 DIRECT INOCULATION
    • 7.3.1 ABILITY TO PROVIDE TESTING FOR MICROBIAL CONTAMINANTS TO DRIVE MARKET
    • TABLE 35 STERILITY TESTING MARKET FOR DIRECT INOCULATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 36 NORTH AMERICA: STERILITY TESTING MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 EUROPE: STERILITY TESTING MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 ASIA: STERILITY TESTING MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 REST OF THE WORLD: STERILITY TESTING MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 OTHER TEST TYPES
    • TABLE 40 STERILITY TESTING MARKET FOR OTHER TEST TYPES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 41 NORTH AMERICA: STERILITY TESTING MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 EUROPE: STERILITY TESTING MARKET FOR OTHER TEST TYPES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 ASIA: STERILITY TESTING MARKET FOR OTHER TEST TYPES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 REST OF THE WORLD: STERILITY TESTING MARKET FOR OTHER TEST TYPES, BY COUNTRY, 2021-2028 (USD MILLION)

8 STERILITY TESTING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 45 STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 PHARMACEUTICAL & BIOLOGICS MANUFACTURING
    • 8.2.1 GROWING PHARMACEUTICAL & BIOPHARMACEUTICAL PRODUCTION CAPACITIES TO DRIVE MARKET
    • TABLE 46 STERILITY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: STERILITY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 EUROPE: STERILITY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 ASIA: STERILITY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 REST OF THE WORLD: STERILITY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 MEDICAL DEVICE MANUFACTURING
    • 8.3.1 RISING DEMAND FOR STERILITY TESTING OF MEDICAL DEVICES TO DRIVE MARKET
    • TABLE 51 STERILITY TESTING MARKET FOR MEDICAL DEVICE MANUFACTURING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 52 NORTH AMERICA: STERILITY TESTING MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 53 EUROPE: STERILITY TESTING MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 ASIA: STERILITY TESTING MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 REST OF THE WORLD: STERILITY TESTING MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 OTHER APPLICATIONS
    • TABLE 56 STERILITY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 57 NORTH AMERICA: STERILITY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 EUROPE: STERILITY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 ASIA: STERILITY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 REST OF THE WORLD: STERILITY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 STERILITY TESTING MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 61 STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL COMPANIES
    • 9.2.1 GROWING EXPANSION OF PRODUCTION CAPACITIES AND STRONG PIPELINE OF NOVEL DRUGS TO DRIVE MARKET
    • TABLE 62 STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 63 NORTH AMERICA: STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 EUROPE: STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 ASIA: STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 REST OF THE WORLD: STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 BIOTECHNOLOGY COMPANIES
    • 9.3.1 RISING R&D INVESTMENTS IN BIOTECH FIRMS TO DRIVE MARKET
    • TABLE 67 STERILITY TESTING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 68 NORTH AMERICA: STERILITY TESTING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: STERILITY TESTING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 ASIA: STERILITY TESTING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 REST OF THE WORLD: STERILITY TESTING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 OTHER END USERS
    • TABLE 72 STERILITY TESTING MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 73 NORTH AMERICA: STERILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 EUROPE: STERILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 ASIA: STERILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 REST OF THE WORLD: STERILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 STERILITY TESTING MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 77 STERILITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 22 NORTH AMERICA: STERILITY TESTING MARKET SNAPSHOT
    • TABLE 78 NORTH AMERICA: STERILITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 NORTH AMERICA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 80 NORTH AMERICA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 81 NORTH AMERICA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 82 NORTH AMERICA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Rising growth in medical devices industry to fuel uptake
    • TABLE 83 US: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 84 US: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 85 US: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 86 US: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Rising demand for pharmaceutical & biologics manufacturing to support market growth
    • TABLE 87 CANADA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 88 CANADA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 89 CANADA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 90 CANADA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    • TABLE 91 EUROPE: STERILITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 EUROPE: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 93 EUROPE: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 EUROPE: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 95 EUROPE: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Favorable R&D funding by federal & state governments to fuel uptake
    • TABLE 96 GERMANY: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 97 GERMANY: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 GERMANY: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 99 GERMANY: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Rising development of biotechnology manufacturing firms to drive market
    • TABLE 100 UK: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 101 UK: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 UK: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 103 UK: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Rising government initiatives for biologics manufacturing to support market growth
    • TABLE 104 FRANCE: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 105 FRANCE: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 FRANCE: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 107 FRANCE: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Favorable government support for establishment of biotech startups to support market growth
    • TABLE 108 ITALY: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 109 ITALY: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 ITALY: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 111 ITALY: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing focus on development of APIs to fuel uptake
    • TABLE 112 SPAIN: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 113 SPAIN: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 SPAIN: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 115 SPAIN: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 116 REST OF EUROPE: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 117 REST OF EUROPE: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 118 REST OF EUROPE: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 119 REST OF EUROPE: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 EUROPE: RECESSION IMPACT
  • 10.4 ASIA
    • FIGURE 23 ASIA: STERILITY TESTING MARKET SNAPSHOT
    • TABLE 120 ASIA: STERILITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 121 ASIA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 122 ASIA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 123 ASIA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 124 ASIA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Favorable government policies to increase drug manufacturing to drive market
    • TABLE 125 CHINA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 126 CHINA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 127 CHINA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 128 CHINA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising investments for cell & gene therapy facilities to support market growth
    • TABLE 129 JAPAN: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 130 JAPAN: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 JAPAN: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 132 JAPAN: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Increasing demand for biosimilars to drive market
    • TABLE 133 INDIA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 134 INDIA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 INDIA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 136 INDIA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Significant exports of pharmaceutical drugs to fuel uptake of sterility testing services
    • TABLE 137 SOUTH KOREA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 138 SOUTH KOREA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 139 SOUTH KOREA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 140 SOUTH KOREA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 REST OF ASIA
    • TABLE 141 REST OF ASIA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 142 REST OF ASIA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 143 REST OF ASIA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 144 REST OF ASIA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 145 REST OF THE WORLD: STERILITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 146 REST OF THE WORLD: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 147 REST OF THE WORLD: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 148 REST OF THE WORLD: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 149 REST OF THE WORLD: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.1 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN
      • 10.5.1.1 Growing vaccine production to propel demand for sterility testing
    • TABLE 150 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 151 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 152 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 153 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 PACIFIC AND OCEANIA
      • 10.5.2.1 Improving investments in pharmaceutical R&D to fuel uptake
    • TABLE 154 PACIFIC AND OCEANIA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 155 PACIFIC AND OCEANIA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 PACIFIC AND OCEANIA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 157 PACIFIC AND OCEANIA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.3 AFRICA
      • 10.5.3.1 Favorable government support for healthcare infrastructure to drive market
    • TABLE 158 AFRICA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 159 AFRICA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 AFRICA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 161 AFRICA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • TABLE 162 STERILITY TESTING MARKET: KEY PLAYER STRATEGIES
  • 11.3 MARKET SHARE ANALYSIS
    • FIGURE 24 STERILITY TESTING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS IN 2022 (LEADING FOUR COMPANIES)
    • TABLE 163 STERILITY TESTING MARKET: INTENSITY OF COMPETITIVE RIVALRY
  • 11.4 REVENUE SHARE ANALYSIS OF KEY PLAYERS
    • FIGURE 25 STERILITY TESTING MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS (TOP FOUR)
  • 11.5 COMPANY EVALUATION QUADRANT
    • FIGURE 26 STERILITY TESTING MARKET: COMPANY EVALUATION MATRIX (2022)
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
  • 11.6 COMPANY EVALUATION QUADRANT: STARTUPS/SMES
    • FIGURE 27 STERILITY TESTING MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
  • 11.7 COMPETITIVE BENCHMARKING
    • 11.7.1 COMPANY PRODUCT FOOTPRINT
    • TABLE 164 STERILITY TESTING MARKET: PRODUCT PORTFOLIO ANALYSIS
    • 11.7.2 COMPANY GEOGRAPHIC FOOTPRINT
    • TABLE 165 STERILITY TESTING MARKET: GEOGRAPHIC ANALYSIS
  • 11.8 COMPETITIVE SCENARIO
    • TABLE 166 STERILITY TESTING MARKET: DEALS (JANUARY 2019-JANUARY 2023)
    • TABLE 167 STERILITY TESTING MARKET: OTHER DEVELOPMENTS (JANUARY 2019-JANUARY 2023)

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS

(Business Overview, Products/Services Offered, Recent Developments, and MnM View)*

    • 12.1.1 MERCK KGAA
    • TABLE 168 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2021)
    • 12.1.2 CHARLES RIVER LABORATORIES
    • TABLE 169 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 29 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2021)
    • 12.1.3 BIOMERIEUX SA
    • TABLE 170 BIOMERIEUX SA: BUSINESS OVERVIEW
    • FIGURE 30 BIOMERIEUX SA: COMPANY SNAPSHOT (2021)
    • 12.1.4 SGS S.A.
    • TABLE 171 SGS SA: BUSINESS OVERVIEW
    • FIGURE 31 SGS S.A.: COMPANY SNAPSHOT (2021)
    • 12.1.5 SARTORIUS AG
    • TABLE 172 SARTORIUS AG: BUSINESS OVERVIEW
    • FIGURE 32 SARTORIUS AG: COMPANY SNAPSHOT (2022)
    • 12.1.6 THERMO FISHER SCIENTIFIC INC.
    • TABLE 173 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 33 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
    • 12.1.7 WUXI APPTEC
    • TABLE 174 WUXI APPTEC: BUSINESS OVERVIEW
    • 12.1.8 SAMSUNG BIOLOGICS
    • TABLE 175 SAMSUNG BIOLOGICS: BUSINESS OVERVIEW
    • FIGURE 34 SAMSUNG BIOLOGICS: COMPANY SNAPSHOT (2021)
    • 12.1.9 GENSCRIPT
    • TABLE 176 GENSCRIPT: BUSINESS OVERVIEW
    • FIGURE 35 GENSCRIPT: COMPANY SNAPSHOT (2021)
    • 12.1.10 PACIFIC BIOLABS
    • TABLE 177 PACIFIC BIOLABS: BUSINESS OVERVIEW
    • 12.1.11 NELSON LABORATORIES, LLC
    • TABLE 178 NELSON LABORATORIES, LLC: BUSINESS OVERVIEW
  • Business Overview, Products/Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 PACE ANALYTICAL
    • 12.2.2 RAPID MICRO BIOSYSTEMS, INC.
    • 12.2.3 TENTAMUS
    • 12.2.4 SINGOTA SOLUTIONS
    • 12.2.5 NEOPHARM LABS INC.
    • 12.2.6 LEXAMED
    • 12.2.7 ASTELL SCIENTIFIC LTD
    • 12.2.8 HIMEDIA LABORATORIES
    • 12.2.9 PALL CORPORATION (PART OF DANAHER CORPORATION)
    • 12.2.10 BOSTON ANALYTICAL
    • 12.2.11 SOLVIAS AG
    • 12.2.12 BD

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS